Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL. (Q40102556)
scientific article
Language:
Current Data About Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
(P31) (Q13442814)
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

(P304) 490-498
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

(P407) (Q1860)

(P433) 4
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

(P478) 27
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

(P577) Monday, July 23, 2007
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

(P1433) (Q1568657)
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

(P1476) "Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL." (language: en)
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

(P2093) S I Bae
(P1545) 1
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

V Cheriyath
(P1545) 2
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

B S Jacobs
(P1545) 3
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

F J Reu
(P1545) 4
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

E C Borden
(P1545) 5
(P248)
(P698) 17653094
(P813) Sunday, September 17, 2017

(P2860) (Q28280897)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q47670151)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q28646425)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q28646554)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q24318710)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q29547437)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q29617274)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q40082103)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q40654530)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q44488215)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q38344941)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q34130066)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q28200039)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q28115670)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q34378197)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q34542069)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q43011704)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

(Q27861006)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655
(P813) Sunday, January 21, 2018

other details
description scientific article

External Links
(P356) 10.1038/SJ.ONC.1210655
(P698) 17653094
(P5875) 6185899
(P6179) 1022703258